KOURTNEY RUFF: Open Payments
NPI 1720787641 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 28 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $328 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Noven Therapeutics, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Corium, LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, INGREZZA, Xelstrym, FANAPT, Jornay PM.
Industry payments across FL — which companies pay providers there.
